Molecular Characterization of Oculocutaneous Albinism in Consanguineous Pakistani Families: Unraveling Disease-Causing Pathogenic Variants in OCA2 and TYR Genes for Precision Diagnosis
Authors:
- Haiba KaulHaiba Kaul
- Shagufta NazShagufta Naz
- Hafiz Ishfaq AhmadHafiz Ishfaq Ahmad
- Nameerah SaleemNameerah Saleem
- Muhammad ShakilMuhammad Shakil
- Sabika FirasatSabika Firasat
- Bilal MajeedBilal Majeed
- Saima SharifSaima Sharif
- Farzana RashidFarzana Rashid
- Abdullah EtezazAbdullah Etezaz
- Muhammad Umer KhanMuhammad Umer Khan
- 9 May 2025
- journal article
- research article
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (2) , 2048-2065
Abstract
Oculocutaneous albinism is a rare genetic disorder characterized by the absence or reduction of melanin pigment in the skin, hair, and eyes, leading to various visual and dermatological challenges. To shed light on the molecular pathology of OCA in consanguineous Pakistani families, we conducted whole-exome sequencing on affected individuals from two families. We identified disease-causing homozygous mutations in the TYR (NM_000372) and OCA2 (NM_000275.3) genes that segregated within their respective pedigrees. In family AL01, we identified a novel mutation in the TYR gene, resulting in a missense change, c.1280T>C, leading to p.V427A. In family AL02, we detected a splice site variant, c.1045-15T>G in OCA2 gene. Protein model of the V427A mutation within the tyrosinase protein predicted that as the mutant amino acid was considerably smaller in size than the wild type, it might have created a potential gap in protein’s core structure. The V427A mutation is positioned centrally within the Lumenal melanosome repeat domain raises concerns about potential structural alterations in this domain due to disparities between the wild-type and mutant residue, potentially leading to a loss of function in this repeated region. Our study provides a deeper understanding of the molecular basis of OCA in consanguineous Pakistani families by identifying disease-causing mutations in the TYR and OCA2 genes. The novel TYR mutation, V427A, offers insights on the structural consequences of this mutation, which could have implications for understanding the pathology of OCA and potentially effecting future diagnostic and therapeutic approaches for individuals affected by this rare genetic disorder.Keywords
This publication has 35 references indexed in Scilit:
- Generation and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A diseaseJournal of Biosciences, 2024
- TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestationsExperimental Eye Research, 2023
- SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani familiesMolecular Biology Reports, 2021
- Adaptive evolution of peptidoglycan recognition protein family regulates the innate signaling against microbial pathogens in vertebratesMicrobial Pathogenesis, 2020
- Mutations in TYR and OCA2 associated with oculocutaneous albinism in Pakistani familiesMeta Gene, 2018
- Structure of Human Tyrosinase Related Protein 1 Reveals a Binuclear Zinc Active Site Important for MelanogenesisAngewandte Chemie International Edition, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigreeJournal of Dermatological Science, 2013
- Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: Four approaches that performed well in CASP8Proteins: Structure, Function, and Bioinformatics, 2009
- WHAT IF: A molecular modeling and drug design programJournal of Molecular Graphics, 1990